Tuesday, Aug. 25th, 2020
10:00 am - 11:00 am Pacific Time
1:00 pm - 2:00 pm Eastern Time
|Life Sciences Webinar Preview|
Intellectual property (IP) accounts for a significant portion of the corporate value of Biotech, Pharmaceutical and Medical Device companies, particularly in the early, pre-revenue stage. It is the main asset by which startups leverage funding, generate revenues or manage to secure a successful exit. That being said, the recent COVID-19 pandemic has heightened some of the frictions surrounding IP and technology monetization rights, particularly when it comes to inventions resulting from federally-funded R&D.
This webinar will explore the critical relationship between IP and valuation in the life sciences sector, while focusing on the unique role IP plays in startup funding and exits (M&A or IPO). Through case studies and industry metrics, we will explore some of the key IP valuation models, how they are impacted by recent events (such as the COVD-19 epidemic), and what can be done to optimize valuation and return on investment in times of crisis.
Thursday, Aug. 27th, 2020
6:00 pm - 9:00 pm Pacific Time
Intellectual property (IP) assets are the most valuable assets for high-tech companies of all sizes, particularly for startups. This webinar will help entrepreneurs understand the value of their IP as a strategic business asset, throughout the lifecycle of a business from the early stage to exit.
Efrat Kasznik, a Silicon Valley-based IP and startup valuation expert, and a Stanford Lecturer, will share her experience and insights on topics including:
- How to create an IP portfolio that will increase your startup valuation?
- How to leverage your IP for funding and growth?
- What are the types of IP value that investors are looking for?
- What are some of the mistakes to avoid when managing an IP portfolio?
Efrat Kasznik, President, Foresight Valuation Group, LLC
Efrat Kasznik is President of Foresight Valuation Group, LLC, a Silicon-Valley based IP valuation and strategy consulting firm, and a Lecturer at the Stanford Graduate School of Business. Efrat is a valuation and intellectual property expert with two decades of consulting experience, focusing on assisting IP holders across industries with the creation, commercialization and monetization of their intangible assets. She helps clients, ranging in size from Fortune 100 companies to start-ups, with IP and business valuations in support of licensing deals, IP and technology acquisitions, M&A transactions, financial reporting, strategic planning and fundraising. She frequently serves as a testifying expert in disputes involving IP and startup valuations and damages. Efrat currently serves as Chair of the High-Tech Sector - LES USA-Canada, and has been recognized as one of the top IP strategists in the world by IAM every year since 2013.